|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:795-803
© 2000 The American Association for Thoracic Surgery
GENERAL THORACIC SURGERY |
From the Section of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, New York, NYa; and Biological Therapeutics Laboratoryb and Divisions of Thoracic Surgeryc and Surgical Oncology,d University of Pittsburgh Cancer Institute, Pittsburgh, Pa.
Supported by "Fondation pour la Recherche Medicale" (grant No. SE 000619-01) by the Division of Thoracic Surgery and the UPCI Biological Therapeutics Program (NCI-1POI CA 68067-01 and National Institutes of Health 1POI DE12321, both to M.T.L.).
Address for reprints: Tracey L. Weigel, MD, Section of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (E-mail: weigelt{at}mskcc.org ).
Objective: Our objective was to determine whether paclitaxel-induced apoptosis in human lung cancer cells is Fas dependent.
Methods: Human lung cancer cell lines were evaluated for morphologic evidence of apoptosis, DNA fragmentation (TUNEL positivity), and caspase-3 activation after paclitaxel treatment. Human lung adenocarcinoma, squamous cell carcinoma, undifferentiated lung carcinoma, and bronchoalveolar carcinoma cell lines were each cultured in 10 µmol/L paclitaxel.
Results: After 24 hours of culture in paclitaxel, a 22% to 69% increase in the number of apoptotic cells was evident by means of methylene blue-azure A-eosin staining with characteristic blebbing and nuclear condensation. TUNEL assay also confirmed an increase of 19.9% to 73.0% of cells with nuclear fragmentation. Caspase-3 activity, assayed by Z-DEVD cleavage, increased from 20% to 215% (P < .05). ZB4, an antagonistic anti-Fas antibody, did not block paclitaxel induction of caspase-3 activity (155.8 vs 165.8 U, not significant). Apoptotic morphologic changes were inhibited in cells cultured in the presence of paclitaxel and Ac-DEVD-CHO, a caspase-3 inhibitor.
Conclusions: Paclitaxel induces apoptosis in lung cancer cell lines, as assessed by a consistent increase in caspase-3 activity, DNA laddering, and characteristic morphologic changes. Paclitaxel-induced apoptosis in human lung cancer cells is associated with caspase-3 activation but is not Fas dependent.
This article has been cited by other articles:
![]() |
L. Sun, T. Chen, X. Wang, Y. Chen, and X. Wei Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells Evid. Based Complement. Altern. Med., July 10, 2009; (2009) nep082v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Fennell Caspase Regulation in Non-Small Cell Lung Cancer and its Potential for Therapeutic Exploitation Clin. Cancer Res., March 15, 2005; 11(6): 2097 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Piechocki, F. Lonardo, J. F. Ensley, T. Nguyen, H. Kim, and G. H. Yoo Anticancer Activity of Docetaxel in Murine Salivary Gland Carcinoma Clin. Cancer Res., March 1, 2002; 8(3): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |